Chembio Diagnostics
CEMIUnlisted companyMore about Chembio Diagnostics
- Acquisitions and changes
- No longer listed: ticker CEMI is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #3,844 (Jan 2020) · #3,714 (Jan 2021) · #5,144 (Jan 2022) · #5,636 (Dec 2022)
Lobbying by Chembio Diagnostics#
$10 K spent on lobbying the US Congress and federal agencies in 2022, most often on manufacturing and medical/disease research/clinical labs.
- Manufacturing1 report
- Medical/Disease Research/Clinical Labs1 report
Lobbying firms hired in 2022
K&L GATES LLP $10 K
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2022 | $10 K | — | 4 |
| 2021 | $40 K | — | 4 |
Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Chembio Diagnostics, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero
Product recalls by Chembio Diagnostics#
1 recalls since 2015, 126 units in the notices that give a number. Medical devices (FDA): 1.
| Date | What and why | Units | Notice |
|---|---|---|---|
| Chembio DPP¿ Micro Reader for use with the DPP¿ COVID-19 IgM/IgG System- Rapid immunochromatographic test for the qualitative detection and differentiation of Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies to SARS-CoV-2 in fingerstick whole blood, venous whole blood, serum, or plasma (lithium heparin or EDTA. Mode… (and 2 more products)FDA revocation of the Emergency Use Authorization due to performance issuesMedical devicesClass II | 126 | Z-2808-2020 |
Source: NHTSA, CPSC and FDA recall notices. Recalls filed under a subsidiary with a different name may be missing. The number of recalls says nothing about their seriousness
Peer comparison · Diagnostics and Research
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Chembio Diagnostics🇺🇸 | $8 M | — | — | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
| Danaher Corporation🇺🇸 | $166.7 B | 38.5× | 16.9% | +2.9% |
| WuXi AppTec Co., Ltd.🇨🇳 | $70.4 B | 25.4× | 42.1% | — |
| Natera, Inc.🇺🇸 | $58.7 B | — | -5.7% | +35.9% |
| Siemens Healthineers AG🇩🇪 | $52.8 B | 22.9× | 8.7% | — |
| Lonza Group AG🇨🇭 | $51.9 B | — | -4.2% | — |
| Agilent Technologies, Inc.🇺🇸 | $48.8 B | 33.9× | 19.5% | +6.7% |
| IQVIA Holdings Inc.🇺🇸 | $45.1 B | 32.4× | 8.1% | +5.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Thermo Fisher Scientific Inc.$253.8 B
- Danaher Corporation$166.7 B
- WuXi AppTec Co., Ltd.$70.4 B
- Natera, Inc.$58.7 B
- Siemens Healthineers AG$52.8 B
- Lonza Group AG$51.9 B
Sources and freshness
- Market cap:
- Dec 25, 2022 (last known)
- Profile updated:
- Nov 14, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Chembio Diagnostics? Verify and update this profile — free
Show Chembio Diagnostics's ranking on your website Get the badge
The badge updates itself as the ranking changes.